Park Ha Biological Technology
Quarterly Financials
| Values in thousands | 2025-04-30 |
|---|---|
Revenue | $1,239 |
Gross Profit | 1,180 |
EBITDA | -19,641 |
EBIT | -19,657 |
Net Income | -19,835 |
Net Change In Cash | 1,239 |
Free Cash Flow | 121 |
Cash | 1,351 |
Basic Shares | 29,374 |
Annual Financials
| Values in thousands | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|
Revenue | $2,381 | $2,459 | $1,919 | $931 |
Gross Profit | 2,186 | 2,148 | 1,410 | 619 |
EBITDA | 816 | 1,200 | 220 | -444 |
EBIT | 793 | 1,180 | 190 | -483 |
Net Income | 478 | 852 | 191 | -484 |
Net Change In Cash | 2,381 | 2,459 | 1,919 | 931 |
Free Cash Flow | 874 | 103 | 1,430 | -510 |
Cash | 547 | 1,033 | 574 | 72 |
Basic Shares | 26,200 | 26,200 | 26,200 | 26,200 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-07-31 | -$0.74 |
2025-01-31 | $0.02 |
